ExodusPoint Capital Management, LP - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 91 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2021$95,000
-82.2%
22,184
-86.1%
0.00%
-87.5%
Q1 2021$533,000
+27.8%
160,048
+36.2%
0.01%
+100.0%
Q4 2020$417,000
+917.1%
117,478
+807.6%
0.00%
+300.0%
Q3 2020$41,000
+32.3%
12,944
-23.9%
0.00%0.0%
Q2 2020$31,000
+121.4%
17,000
+22.6%
0.00%0.0%
Q1 2020$14,000
-86.3%
13,869
-62.1%
0.00%
-50.0%
Q4 2019$102,000
+67.2%
36,559
-7.9%
0.00%0.0%
Q3 2019$61,00039,7000.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Whitefort Capital Management, LP 11,895,477$24,147,81812.66%
Two Seas Capital LP 8,280,818$16,810,0613.38%
FourWorld Capital Management LLC 1,341,907$2,724,0710.51%
Tejara Capital Ltd 180,077$365,5560.21%
Woodline Partners LP 4,719,903$9,581,4030.11%
Hudson Bay Capital Management LP 8,299,808$16,848,6100.07%
Kepos Capital LP 155,691$3160.06%
Virtus ETF Advisers LLC 40,040$81,2810.05%
Centiva Capital, LP 1,071,705$2,175,5610.05%
Kades & Cheifetz LLC 20,000$40,6000.03%
View complete list of ARBUTUS BIOPHARMA CORP shareholders